Patient satisfaction, needs, and preferences concerning information dispensation at the emergency department: a cross-sectional observational study

Autor: Marank de Steenwinkel, Juanita A. Haagsma, Esther C. M. van Berkel, Lotte Rozema, Pleunie P. M. Rood, Marna G. Bouwhuis

Publikováno v: International Journal of Emergency Medicine, Vol 15, Iss 1, Pp 1-8 (2022)

Abstract Background Patient satisfaction is an important indicator of emergency care quality and has been associated with information dispensation at the emergency department (ED). Optimal information dispensation could improve patient experience and

Externí odkaz: https://doaj.org/article/42b49f98ac5d4297b6305724ba3800fa

Patient satisfaction, needs, and preferences concerning information dispensation at the emergency department: a cross-sectional observational study

Autor: Juanita A. Haagsma, Pleunie P.M. Rood, Esther C.M. van Berkel, Marank de Steenwinkel, Marna G. Bouwhuis, Lotte Rozema

Publikováno v: International Journal of Emergency Medicine, Vol 15, Iss 1, Pp 1-8 (2022)
International Journal of Emergency Medicine, 15(1):5. Springer London

Background Patient satisfaction is an important indicator of emergency care quality and has been associated with information dispensation at the emergency department (ED). Optimal information dispensation could improve patient experience and expectat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57c60363ef3f69fbfb5db824811a2269
https://doaj.org/article/42b49f98ac5d4297b6305724ba3800fa

Prognostic and predictive value of YKL-40 in stage IIB-III melanoma

Autor: Ib Jarle Christensen, Julia S. Johansen, Lars Bastholt, Stefan Suciu, Henrik Schmidt, Merete Krogh, Marna G. Bouwhuis, Johan Hansson, Alexander M.M. Eggermont, Peter Nørgaard

Publikováno v: Krogh, M, Christensen, I, Bouwhuis, M, Johansen, J S, Nørgaard, P, Schmidt, H, Hansson, J, Suciu, S, Eggermont, A M M, Bastholt, L & Nordic Melanoma Group and EORTC Melanoma Group 2016, ' Prognostic and predictive value of YKL-40 in stage IIB-III melanoma ', Melanoma Research, vol. 26, no. 4, pp. 367-76 . https://doi.org/10.1097/CMR.0000000000000237
Krogh, M, Christensen, I, Bouwhuis, M, Johansen, J S, Nørgaard, P, Schmidt, H, Hansson, J, Suciu, S, Eggermont, A M M, Bastholt, L & Nordic Melanoma Group and EORTC Melanoma Group 2016, ' Prognostic and predictive value of YKL-40 in stage IIB-III melanoma ', Melanoma Research, vol. 26, no. 4, pp. 367-376 . https://doi.org/10.1097/CMR.0000000000000237
Melanoma Research, 26(4), 367-376. Lippincott Williams & Wilkins

This study investigates the prognostic and predictive value of YKL-40 in stage IIB-III melanoma patients who were randomized to adjuvant interferon α-2b (IFN) or observation. Serum YKL-40 was determined postoperatively in patients from the Nordic IF

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c2b4a125a416d8f3a3851aa358d182
https://doi.org/10.1097/cmr.0000000000000237

Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: A corollary study to EORTC trial 18952

Autor: José Thomas, Marna G. Bouwhuis, Ghanem Elias Ghanem, Wim H. J. Kruit, Konstantin Stoitchkov, Poulam M. Patel, Veronique Cocquyt, A.M.M. Eggermont, Danielle Lienard, Stefan Suciu, François Sales

Publikováno v: European Journal of Cancer, 47(3), 361-368. Elsevier Ltd.

S100B is a prognostic factor for melanoma as elevated levels correlate with disease progression and poor outcome. We determined its prognostic value based on updated information using serial determinations in stage IIb/III melanoma patients. 211 Pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::322e48f835358d604fa0768c27cddc49
https://pure.eur.nl/en/publications/ff554bde-5f22-4e1e-ad87-d9a483b8f41f

Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-alpha (EORTC 18 952) and prognostic value on treatment outcome

Autor: Alexander M.M. Eggermont, Sandra Collette, Els R. de Groot, Lucien A. Aarden, A. J. G. Swaak, Wim H. J. Kruit, Stefan Suciu, Timo L.M. ten Hagen, Marna G. Bouwhuis

Publikováno v: Melanoma Research, 21(4), 344-351. Lippincott Williams & Wilkins
Melanoma research, 21(4), 344-351. Lippincott Williams and Wilkins

Adjuvant therapy with interferon-alpha (IFN) only benefits a small subgroup of melanoma patients and a predictive marker selecting responders does not exist. IFN induces increased ferritin and decreased C-reactive protein (CRP) levels; however, an as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f14d3dcc43481cdc4b55563202643dc2
https://doi.org/10.1097/CMR.0b013e328346c17f